A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms

Weill Cornell Medicine and New York - Presbyterian Hospital, New York

Augusta University - Georgia Cancer Center, Augusta

University of Alabama - Birmingham Comprehensive Cancer Center, Birmingham

Norton Cancer Institute, Louisville

Cleveland Clinic Taussig Cancer Institute, Cleveland

University of Texas MD Anderson Cancer Center, Houston

HonorHealth Research Institute, Scottsdale

University of Southern California Keck School of Medicine, Los Angeles

University of Alberta Hospital - Hematology Research, Edmonton

Princess Margaret Hospital, Toronto